306 related articles for article (PubMed ID: 29566148)
1. Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
Matsumura N; Zordoky BN; Robertson IM; Hamza SM; Parajuli N; Soltys CM; Beker DL; Grant MK; Razzoli M; Bartolomucci A; Dyck JRB
Cardiovasc Res; 2018 Aug; 114(10):1350-1359. PubMed ID: 29566148
[TBL] [Abstract][Full Text] [Related]
2. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
Zhu W; Reuter S; Field LJ
Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
[TBL] [Abstract][Full Text] [Related]
3. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats.
Liu G; Liu Y; Wang R; Hou T; Chen C; Zheng S; Dong Z
Cardiovasc Ther; 2016 Aug; 34(4):216-24. PubMed ID: 27097055
[TBL] [Abstract][Full Text] [Related]
5. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.
Dolinsky VW; Rogan KJ; Sung MM; Zordoky BN; Haykowsky MJ; Young ME; Jones LW; Dyck JR
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E243-53. PubMed ID: 23695218
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
Bian Y; Sun M; Silver M; Ho KK; Marchionni MA; Caggiano AO; Stone JR; Amende I; Hampton TG; Morgan JP; Yan X
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1974-83. PubMed ID: 19801490
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice.
Maayah ZH; Alam AS; Takahara S; Soni S; Ferdaoussi M; Matsumura N; Zordoky BN; Eisenstat DD; Dyck JRB
FEBS Lett; 2021 Jun; 595(12):1681-1695. PubMed ID: 33876420
[TBL] [Abstract][Full Text] [Related]
8. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
9. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
[TBL] [Abstract][Full Text] [Related]
10. Empagliflozin prevents doxorubicin-induced myocardial dysfunction.
Sabatino J; De Rosa S; Tammè L; Iaconetti C; Sorrentino S; Polimeni A; Mignogna C; Amorosi A; Spaccarotella C; Yasuda M; Indolfi C
Cardiovasc Diabetol; 2020 May; 19(1):66. PubMed ID: 32414364
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
12. Dietary cyanidin 3-glucoside from purple corn ameliorates doxorubicin-induced cardiotoxicity in mice.
Petroni K; Trinei M; Fornari M; Calvenzani V; Marinelli A; Micheli LA; Pilu R; Matros A; Mock HP; Tonelli C; Giorgio M
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):462-469. PubMed ID: 28428026
[TBL] [Abstract][Full Text] [Related]
13. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
[TBL] [Abstract][Full Text] [Related]
14. Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity.
Feng K; Liu Y; Sun J; Zhao C; Duan Y; Wang W; Yan K; Yan X; Sun H; Hu Y; Han J
Biomed Pharmacother; 2021 Jun; 138():111531. PubMed ID: 34311530
[TBL] [Abstract][Full Text] [Related]
15. Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway.
Yan F; Liu R; Zhuang X; Li R; Shi H; Gao X
J Cardiovasc Transl Res; 2021 Apr; 14(2):355-364. PubMed ID: 32671648
[TBL] [Abstract][Full Text] [Related]
16. p38δ genetic ablation protects female mice from anthracycline cardiotoxicity.
George SA; Kiss A; Obaid SN; Venegas A; Talapatra T; Wei C; Efimova T; Efimov IR
Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H775-H786. PubMed ID: 32822209
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
Zheng D; Zhang Y; Zheng M; Cao T; Wang G; Zhang L; Ni R; Brockman J; Zhong H; Fan GC; Peng T
Clin Sci (Lond); 2019 Jul; 133(13):1505-1521. PubMed ID: 31266854
[TBL] [Abstract][Full Text] [Related]
18. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.
Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ
Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148
[TBL] [Abstract][Full Text] [Related]
19. Concomitant low-dose doxorubicin treatment and exercise.
Sturgeon K; Schadler K; Muthukumaran G; Ding D; Bajulaiye A; Thomas NJ; Ferrari V; Ryeom S; Libonati JR
Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R685-92. PubMed ID: 25009215
[TBL] [Abstract][Full Text] [Related]
20. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
